Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness

被引:9
|
作者
Bagnato, Sergio [1 ,2 ]
Andriolo, Maria [3 ]
Boccagni, Cristina [1 ,2 ]
Sant'Angelo, Antonino [1 ,2 ]
D'Ippolito, Maria Enza [3 ]
Galardi, Giuseppe [1 ,2 ]
机构
[1] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[2] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[3] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy
关键词
Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY;
D O I
10.1080/02699052.2018.1479042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [31] The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients
    Sancesario, Giulia M.
    Cencioni, Maria T.
    Esposito, Zaira
    Borsellino, Giovanna
    Nuccetelli, Marzia
    Martorana, Alessandro
    Battistini, Luca
    Sorge, Roberto
    Spalletta, Gianfranco
    Ferrazzoli, Davide
    Bernardi, Giorgio
    Bernardini, Sergio
    Sancesario, Giuseppe
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (04) : 865 - 878
  • [32] Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis
    Fiaux do Nascimento, Kenia Kelly
    Silva, Kelly P.
    Malloy-Diniz, Leandro F.
    Butters, Meryl A.
    Diniz, Breno S.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 69 : 35 - 41
  • [33] Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
    Sarlus, Heela
    Eyjolfsdottir, Helga
    Eriksdotter, Maria
    Oprica, Mircea
    Schultzberg, Marianne
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (02) : 495 - 505
  • [34] Amyloid-β, Tau, and 18F-Fluorodeoxyglucose Positron Emission Tomography in Posttraumatic Stress Disorder
    Elias, Alby
    Cummins, Tia
    Lamb, Fiona
    Tyrrell, Regan
    Dore, Vincent
    Williams, Rob
    Rosenfeld, Jeffrey, V
    Hopwood, Malcolm
    Villemagne, Victor L.
    Rowe, Christopher C.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (01) : 163 - 173
  • [35] Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
    Tangen, Gro Gujord
    Sverdrup, Karen
    Taraldsen, Kristin
    Persson, Karin
    Engedal, Knut
    Bekkhus-Wetterberg, Peter
    Knapskog, Anne-Brita
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [36] Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer's disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
    Motta, Caterina
    Di Donna, Martina Gaia
    Bonomi, Chiara Giuseppina
    Assogna, Martina
    Chiaravalloti, Agostino
    Mercuri, Nicola Biagio
    Koch, Giacomo
    Martorana, Alessandro
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [37] Correlation of Specific Amyloid-β Oligomers With Tau in Cerebrospinal Fluid From Cognitively Normal Older Adults
    Handoko, Maureen
    Grant, Marianne
    Kuskowski, Michael
    Zahs, Kathleen R.
    Wallin, Anders
    Blennow, Kaj
    Ashe, Karen H.
    JAMA NEUROLOGY, 2013, 70 (05) : 594 - 599
  • [38] Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
    Kontush, A
    Berndt, C
    Weber, W
    Akopyan, V
    Arlt, S
    Schippling, S
    Beisiegel, U
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 30 (01) : 119 - 128
  • [39] Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
    Oh, Esther S.
    Blennow, Kaj
    Bigelow, George E.
    Inouye, Sharon K.
    Marcantonio, Edward R.
    Neufeld, Karin J.
    Rosenberg, Paul B.
    Troncoso, Juan C.
    Wang, Nae-Yuh
    Zetterberg, Henrik
    Sieber, Frederick E.
    Lyketsos, Constantine G.
    PLOS ONE, 2018, 13 (09):
  • [40] Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus Clinical article
    Tarnaris, Andrew
    Toma, Ahmed K.
    Chapman, Miles D.
    Keir, Geoff
    Kitchen, Neil D.
    Watkins, Laurence D.
    JOURNAL OF NEUROSURGERY, 2011, 115 (01) : 145 - 150